Brief: Histogen Gets Notice of Regaining Compliance With Nasdaq Minimum Bid Price Continued Listing Requirement
17/06/2022 21:17
June 17 (Reuters) - Histogen Inc HSTO.O :
* HISTOGEN - RECEIVED WRITTEN NOTICE FROM NASDAQ STATING
THAT CO
HAS REGAINED COMPLIANCE WITH NASDAQ MINIMUM BID PRICE CONTINUED
LISTING REQUIREMENT
Further company coverage: HSTO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Histogen
See all newsBrief: Histogen Announces Second Adjournment Of Special Meeting Of Stockholders
Brief: Histogen Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Brief: Histogen Announces Board Approval Of Complete Liquidation And Dissolution
Histogen Inc expected to post a loss of 90 cents a share - Earnings Preview
Histogen to explore strategic options, shares up